1-20 of 52
Susan Bal
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Optimal MRD-based end point to support response-adapted treatment cessation in newly diagnosed multiple myeloma

Available to Purchase
Clinical Trials & Observations
Smith Giri, Binod Dhakal, Natalie S. Callander, Eva Medvedova, Kelly Godby, Bhagirathbhai R. Dholaria, Susan Bal, Gayathri Ravi, Saurabh Chhabra, Rebecca W. Silbermann, Luciano Costa
Journal: Blood
Blood (2025) 146 (6): 707–716.
https://doi.org/10.1182/blood.2024027674
Published: 2025
Includes: Supplemental data
Journal Articles

Implications of MRD Progression in Newly Diagnosed Multiple Myeloma (NDMM) Treated with Quadruplet Therapy and Autologous Stem Cell Transplantation

Free
Luciano J. Costa, Eva Medvedova, Binod Dhakal, Bhagirathbhai Dholaria, Smith Giri, Saurabh Chhabra, Susan Bal, Kelly Godby, Gayathri Ravi, Rebecca W. Silbermann, Natalie Callander
Journal: Blood
Blood (2024) 144 (Supplement 1): 363.
https://doi.org/10.1182/blood-2024-201914
Published: 2024
Journal Articles

Longitudinal Trajectories of Patient-Reported Outcomes Among Older Adults with Multiple Myeloma (MM) Following Autologous Stem Cell Transplantation (ASCT)

Free
Victoria Badia, Apoorva Doshi, Gayathri Ravi, Susan Bal, Kelly Godby, Donna Murdaugh, Luciano J. Costa, Grant Williams, Smita Bhatia, Smith Giri
Journal: Blood
Blood (2024) 144 (Supplement 1): 2387.
https://doi.org/10.1182/blood-2024-205712
Published: 2024
Journal Articles

Optimal MRD-Based Endpoint in the Setting of Upfront Quadruplets (QUADs) to Support Response-Adapted Treatment Cessation in Newly Diagnosed Multiple Myeloma (NDMM)

Free
Smith Giri, Binod Dhakal, Natalie Callander, Eva Medvedova, Kelly Godby, Susan Bal, Gayathri Ravi, Saurabh Chhabra, Rebecca W. Silbermann, Luciano J. Costa
Journal: Blood
Blood (2024) 144 (Supplement 1): 257.
https://doi.org/10.1182/blood-2024-205611
Published: 2024
Journal Articles

Efficacy and Safety with Extended Follow-up in a Phase 1 Study of BMS-986393, a G Protein-Coupled Receptor Class C Group 5 Member D (GPRC5D)-Targeted CAR T Cell Therapy, in Patients (pts) with Heavily Pretreated Relapsed/Refractory (RR) Multiple Myeloma (MM)

Free
Susan Bal, Larry D Anderson, Jr., Omar Nadeem, Jesús G. Berdeja, Adriana Rossi, Tara Gregory, Mehmet Hakan Koçoğlu, Thomas G Martin, Daniel N. Egan, Luciano J. Costa, Hongxiang Hu, Jinjie Chen, Chaoqun Mei, Naomey Sarkis, Alok Shrestha, Safiyyah Ziyad, Wei-Ming Kao, Allison J Kaeding, Michael R. Burgess, Myo Htut
Journal: Blood
Blood (2024) 144 (Supplement 1): 922.
https://doi.org/10.1182/blood-2024-201356
Published: 2024
Journal Articles

BMS-986393, a G Protein-Coupled Receptor Class C Group 5 Member D (GPRC5D)-Targeted CAR T Cell Therapy, in Patients (pts) with Relapsed/Refractory (RR) Multiple Myeloma (MM) and 1-3 Prior Regimens: Updated Phase 1 Safety and Efficacy Results

Free
Susan Bal, Myo Htut, Jesús G. Berdeja, Larry D Anderson, Jr., Adriana Rossi, Tara Gregory, Thomas G Martin, Luciano J. Costa, Hongxiang Hu, Jinjie Chen, Chaoqun Mei, Naomey Sarkis, Alok Shrestha, Safiyyah Ziyad, Wei-Ming Kao, Allison J Kaeding, Michael R. Burgess, Omar Nadeem
Journal: Blood
Blood (2024) 144 (Supplement 1): 2069.
https://doi.org/10.1182/blood-2024-203279
Published: 2024
Journal Articles

Phase 2 Trial of Siltuximab for the Treatment of Cytokine Release Syndrome and Immune Effector Cell Associated Neurotoxicity Related to CAR-T Cell Therapy

Free
Mayur S. Narkhede, Antonio Di Stasi, Lauren Kelly Shea, Susan Bal, Gayathri Ravi, Gaurav Goyal, Pamela Hardwick, Smith Giri, Donna Salzman, Ravi Bhatia, Luciano J. Costa, Amitkumar Mehta
Journal: Blood
Blood (2024) 144 (Supplement 1): 3449.
https://doi.org/10.1182/blood-2024-205205
Published: 2024
Journal Articles

Real World Evidence of Outcomes of Patients Treated with Talquetamab in a Heavily Pretreated Population with Multiple Myeloma with High Exposure to Prior BCMA Therapies- a Report from the IMWG Consortium

Free
Murali Janakiram, Carlyn Rose Tan, Rakesh Popat, Joaquín Martínez Lopez, Efstathios Kastritis, Chris Lau, Wee-Joo Chng, Prashant Kapoor, Hira Mian, Susan Bal, Ajay K. Nooka, Andre De Menezes Silva Corraes, Magdalena Corona, Arnab Chowdhury, Yi Lin, Thomas G Martin, Amrita Y Krishnan
Journal: Blood
Blood (2024) 144 (Supplement 1): 3368.
https://doi.org/10.1182/blood-2024-211167
Published: 2024
Journal Articles

Feasibility and Accuracy of Bioelectric Impedance Analysis in Estimating Skeletal Muscle Mass in Older Adults with Multiple Myeloma

Free
Apoorva Doshi, Abigail Tucker, Gayathri Ravi, Susan Bal, Kelly Godby, William Evans, Mahalakshmi Shubha Shankaran, Luciano J. Costa, Grant Williams, Smita Bhatia, Smith Giri
Journal: Blood
Blood (2024) 144 (Supplement 1): 6963.
https://doi.org/10.1182/blood-2024-201688
Published: 2024
Journal Articles

MRD-Guided Sequential Therapy for Deep Response in Newly Diagnosed Multiple Myeloma (NDMM)- Master-2 Trial

Free
Binod Dhakal, Rebecca Silbermann, Timothy M Schmidt, Eva Medvedova, Susan Bal, Smith Giri, Naresh Bumma, Abdullah Mohammad Khan, Andrew J. Cowan, Rajshekhar Chakraborty, Gayathri Ravi, Kelly Godby, Bhagirathbhai Dholaria, Muhamed Baljevic, Bria Gendron, Aimaz Afrough, Gurbakhash Kaur, Mary Kwok, Rahul Banerjee, Zhubin Ghavari, Anita D'Souza, Othman S. Akhtar, Meera Mohan, Henning Schade, Ravi Narra, Yubin Kang, Jeffrey V Matous, Larry D Anderson, Jr., Natalie Callander, Luciano J. Costa
Journal: Blood
Blood (2024) 144 (Supplement 1): 2000.1.
https://doi.org/10.1182/blood-2024-200210
Published: 2024
Journal Articles

Real World Evidence on Patient Reported Outcomes Among Newly Diagnosed Multiple Myeloma Patients Treated with Daratumumab-Based Regimens in Frontline (1L)

Free
Smith Giri, Liton Francisco, Nicole Rafalko, Niodita Gupta-Werner, Joshua Richman, Smita Bhatia, Kelly Godby, Gayathri Ravi, Susan Bal, Marjohn Armoon, Rohan Medhekar, Luciano J. Costa
Journal: Blood
Blood (2024) 144 (Supplement 1): 5151.
https://doi.org/10.1182/blood-2024-203431
Published: 2024
Journal Articles

Decisional Regret Among Older Adults with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation

Free
Apoorva Doshi, Gayathri Ravi, Kelly Godby, Susan Bal, Victoria Badia, Luciano J. Costa, Grant Williams, Smita Bhatia, Smith Giri
Journal: Blood
Blood (2024) 144 (Supplement 1): 3767.
https://doi.org/10.1182/blood-2024-201735
Published: 2024
Journal Articles

Factors Associated with Post-Transplant Complications Among Older Adults with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation

Free
Apoorva Doshi, Gayathri Ravi, Susan Bal, Supriya Maheshwari, Kelly Godby, Luciano J. Costa, Joshua Richman, Grant Williams, Smita Bhatia, Smith Giri
Journal: Blood
Blood (2024) 144 (Supplement 1): 5145.
https://doi.org/10.1182/blood-2024-201737
Published: 2024
Journal Articles

Screening for AL Amyloidosis in Smoldering Multiple Myeloma

Free
Denis Toskic, Mahesh Mansukhani, Ping Zhou, Stephanie Scalia, Xun Ma, Teresa Fogaren, Lisa X. Lee, Alfred Chung, Sascha Alexander Tuchman, Giada Bianchi, Amandeep Godara, Heather J. Landau, Susan Bal, Gurbakhash Kaur, Vaishali Sanchorawala, Gareth Morgan, Hashim Mann, Robert Allen Vescio, Chakra Chaulagain, Cindy Varga, Suzanne Lentzsch, Gheorghe Doros, Raymond Comenzo
Journal: Blood
Blood (2024) 144 (Supplement 1): 6874.
https://doi.org/10.1182/blood-2024-201755
Published: 2024
Journal Articles

Bendamustine Lymphodepletion (LD) Prior to Idecabtagene Vicleucel (Ide-cel) Is Associated with Inferior Outcomes in Relapsed Refractory Multiple Myeloma (RRMM)

Free
Gayathri Ravi, Susan Bal, Kelly Godby, Smith Giri, Courtney Hebert, Binita Parekh, JoAnn Steele, Jessica Brown, Kathy Langley, Luciano Costa
Journal: Blood
Blood (2023) 142 (Supplement 1): 6920.
https://doi.org/10.1182/blood-2023-188323
Published: 2023
Journal Articles

Sonrotoclax (BGB-11417) in Combination with Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma with t(11;14): Safety, Efficacy, and Determination of Recommended Phase 2 Dose

Free
Hang Quach, Doug Sborov, Dickran Kazandjian, Andrew Spencer, Michael Low, Susan Bal, Natalie S. Callander, Huan Cheng, Sheel Patel, Rocco J. Crescenzo, Amit Agarwal, Binod Dhakal
Journal: Blood
Blood (2023) 142 (Supplement 1): 1011.
https://doi.org/10.1182/blood-2023-178735
Published: 2023
Journal Articles

Health Outcome Preferences Among Older Adults with Multiple Myeloma Undergoing Systemic Therapy

Free
Miguel Arias, Clare Ubersax, Abigail Tucker, Susan Bal, Gayathri Ravi, Kelly Godby, Luciano Costa, Grant Williams, Sadeep Shrestha, Smita Bhatia, Smith Giri
Journal: Blood
Blood (2023) 142 (Supplement 1): 2400.
https://doi.org/10.1182/blood-2023-189623
Published: 2023
Journal Articles

Outcomes of Patients with Newly Diagnosed Multiple Myeloma Experiencing Treatment Failure after Upfront Quadruplet Therapy and Autologous Stem Cell Transplantationgayathri Ravi 1 , Susan Bal 1 , Kelly Godby 1 , Smith Giri 1 , Clare Ubersax 1 , Abigail Tucker 1 , Luciano J Costa 1

Free
Gayathri Ravi, Susan Bal, Kelly Godby, Smith Giri, Clare Ubersax, Abigail Tucker, Luciano Costa
Journal: Blood
Blood (2023) 142 (Supplement 1): 1989.
https://doi.org/10.1182/blood-2023-188272
Published: 2023
Journal Articles

Dual Targeting of Slamf-7 and CD38 in Mulitple Myeloma (MM): A Phase II Study of Isatuximab, Elotuzumab, Pomalidomide and Dexamethasone (Isa-EloPD) in Relapsed and/or Refractory MM (RRMM)

Free
Binod Dhakal, Meera Mohan, Ravi Narra, Katie Palen, Aniko Szabo, Tyce Kearl, Gayathri Ravi, Susan Bal, Bryon D. Johnson, Marcelo Pasquini, Anita D'Souza, Parameswaran N. Hari, Luciano Costa
Journal: Blood
Blood (2023) 142 (Supplement 1): 3379.
https://doi.org/10.1182/blood-2023-181266
Published: 2023
Journal Articles

Neurocognitive Performance Changes with Chimeric Antigen Receptor T-Cell Therapy in Patients with Hematologic Malignancies

Free
Smith Giri, Smith Giri, Clare Ubersax, Abigail Tucker, Susan Bal, Kelly Godby, Luciano Costa, Smita Bhatia, Grant Williams, Gayathri Ravi, Mayur Narkhede, Donna Murdaugh
Journal: Blood
Blood (2023) 142 (Supplement 1): 5165.
https://doi.org/10.1182/blood-2023-189872
Published: 2023